OSTX
OS Therapies Incorporated AMEX Listed Aug 1, 2024$1.64
-2.38%
vs $1.68
Mkt Cap $74.7M
52w Low $1.15
40.5% of range
52w High $2.36
50d MA $1.64
200d MA $1.59
P/E (TTM)
—
EV/EBITDA
—
P/B
—
Debt/Equity
0.0x
ROE
471.7%
P/FCF
-0.0x
RSI (14)
50.80
ATR (14)
$0.08
Beta
-2.99
50d MA
$1.64
200d MA
$1.59
Avg Volume
332.2K
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
115 Pullman Crossing Road · Rockville, MD 21638 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | AMC | -0.18 | -0.20 | -12.4% | 1.60 | -1.2% | +1.2% | -2.0% | +1.4% | +8.2% | +0.6% | — |
| May 18, 2026 | AMC | -0.17 | -0.27 | -58.8% | 1.88 | +2.1% | -8.0% | +1.7% | +4.0% | -0.5% | -4.9% | — |
| Mar 31, 2026 | AMC | -0.14 | -0.35 | -157.4% | 1.41 | -2.8% | -3.5% | +0.0% | -6.6% | -3.1% | +1.6% | — |
| Nov 14, 2025 | AMC | -0.16 | -0.21 | -31.2% | 1.80 | -8.3% | -5.0% | +1.2% | -4.6% | -1.8% | +5.6% | — |
| Aug 19, 2025 | AMC | -0.15 | -0.19 | -26.7% | 2.15 | -1.9% | +1.9% | +9.6% | +3.3% | -11.7% | +6.4% | — |
| May 15, 2025 | AMC | -0.11 | -0.18 | -63.6% | 1.66 | +1.2% | -1.2% | -3.0% | +0.0% | -8.8% | +5.5% | — |
| Mar 31, 2025 | AMC | -0.14 | -0.24 | -71.4% | 1.54 | -5.8% | -13.6% | +13.5% | +2.0% | -9.1% | +2.1% | — |
| Nov 15, 2024 | AMC | -0.12 | -0.18 | -50.0% | 2.20 | +0.0% | -6.4% | -14.1% | -2.5% | +7.6% | +5.1% | — |
| Aug 14, 2024 | AMC | -0.26 | -0.26 | +0.0% | 3.16 | -1.9% | +12.0% | -1.7% | +14.7% | -2.8% | +4.1% | — |
| May 20, 2024 | AMC | — | -0.07 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | -0.07 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | -0.09 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | BMO | — | -0.00 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | BMO | — | -0.00 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9 | Roth Capital | Initiates | Buy | $7 | $1.46 | $1.50 | +2.7% | +17.8% | -2.3% | -3.6% | +2.5% | -6.6% |
| Apr 30 | D. Boral Capital | Maintains | Buy → Buy | — | $1.63 | $1.73 | +6.1% | +4.3% | -5.3% | +3.1% | +4.2% | +0.0% |
| Apr 8 | D. Boral Capital | Maintains | Buy → Buy | — | $1.23 | $1.28 | +4.1% | +1.6% | +8.0% | -3.7% | +1.5% | +5.3% |
| Mar 27 | D. Boral Capital | Maintains | Buy → Buy | — | $1.37 | $1.38 | +0.7% | +2.9% | -5.7% | +6.0% | -3.5% | +0.0% |
| Mar 9 | D. Boral Capital | Maintains | Buy → Buy | — | $1.57 | $1.60 | +1.9% | +8.9% | -4.7% | -4.9% | -1.9% | +2.0% |
| Feb 5 | D. Boral Capital | Maintains | Buy → Buy | — | $1.33 | $1.35 | +1.5% | -4.5% | +7.1% | -4.4% | -3.1% | -4.8% |
| Jan 5 | D. Boral Capital | Maintains | Buy → Buy | — | $1.34 | $1.49 | +11.2% | +7.5% | +2.8% | +3.4% | +0.7% | +0.6% |
| Dec 15 | D. Boral Capital | Maintains | Buy → Buy | — | $1.81 | $1.81 | +0.0% | -7.7% | -3.0% | -4.9% | +3.9% | -3.8% |
| Dec 9 | D. Boral Capital | Maintains | Buy → Buy | — | $1.96 | $1.98 | +1.0% | +0.0% | +1.5% | +2.0% | -10.8% | -7.7% |
| Dec 5 | D. Boral Capital | Maintains | Buy → Buy | — | $1.82 | $1.89 | +3.8% | +5.5% | +2.1% | +0.0% | +1.5% | +2.0% |
| Nov 21 | D. Boral Capital | Maintains | Buy → Buy | — | $1.62 | $1.64 | +1.2% | +5.6% | +0.6% | +4.7% | +2.8% | -3.2% |
| Nov 18 | Lake Street | Maintains | Buy → Buy | — | $1.71 | $1.73 | +1.2% | +1.2% | -4.6% | -1.8% | +5.6% | +0.6% |
| Nov 17 | D. Boral Capital | Maintains | Buy → Buy | — | $1.80 | $1.65 | -8.3% | -5.0% | +1.2% | -4.6% | -1.8% | +5.6% |
| Oct 10 | D. Boral Capital | Maintains | Buy → Buy | — | $2.04 | $2.10 | +2.9% | -2.5% | -2.0% | +0.0% | +0.0% | -5.1% |
| Sep 30 | D. Boral Capital | Maintains | Buy → Buy | — | $2.01 | $2.01 | +0.0% | -2.5% | +2.0% | -0.5% | +1.5% | +2.5% |
| Sep 12 | D. Boral Capital | Maintains | Buy → Buy | — | $2.31 | $2.31 | +0.0% | -2.6% | -2.2% | +0.9% | -0.9% | +0.5% |
| Sep 2 | D. Boral Capital | Maintains | Buy → Buy | — | $2.39 | $2.35 | -1.7% | -7.1% | -5.4% | -0.5% | +5.3% | +1.8% |
| Aug 27 | D. Boral Capital | Maintains | Buy → Buy | — | $2.33 | $2.35 | +0.9% | +7.3% | -9.6% | +5.8% | -7.1% | -5.4% |
| Aug 20 | D. Boral Capital | Maintains | Buy → Buy | — | $2.15 | $2.11 | -1.9% | +1.9% | +9.6% | +3.3% | -11.7% | +6.4% |
| Aug 7 | D. Boral Capital | Maintains | Buy → Buy | — | $1.75 | $1.85 | +5.7% | +0.0% | -1.1% | -3.5% | +6.6% | +5.6% |
| Jul 14 | D. Boral Capital | Maintains | Buy → Buy | — | $1.70 | $1.70 | +0.0% | -8.2% | +1.3% | +6.3% | +0.0% | -2.4% |
| Jul 3 | D. Boral Capital | Maintains | Buy → Buy | — | $1.91 | $1.95 | +2.1% | -4.2% | -5.5% | -6.4% | +2.5% | +0.6% |
| Jun 30 | D. Boral Capital | Maintains | Buy → Buy | — | $1.84 | $1.89 | +2.7% | +2.2% | +2.7% | -1.0% | -4.2% | -5.5% |
| Jun 24 | D. Boral Capital | Maintains | Buy → Buy | — | $1.70 | $1.83 | +7.6% | +1.2% | +2.3% | +2.8% | +1.7% | +2.2% |
| Jun 10 | D. Boral Capital | Maintains | Buy → Buy | — | $1.98 | $1.96 | -1.0% | -1.0% | -3.6% | -2.6% | -1.1% | +4.4% |
| Jun 9 | D. Boral Capital | Maintains | Buy → Buy | — | $1.67 | $1.71 | +2.4% | +18.6% | -1.0% | -3.6% | -2.6% | -1.1% |
| May 15 | D. Boral Capital | Maintains | Buy → Buy | — | $1.80 | $1.80 | +0.0% | -7.8% | -1.2% | -3.0% | +0.0% | -8.8% |
| Apr 22 | D. Boral Capital | Maintains | Buy → Buy | — | $1.49 | $1.50 | +0.7% | +2.0% | +2.0% | +3.9% | -0.6% | +13.8% |
| Apr 7 | D. Boral Capital | Maintains | Buy → Buy | — | $1.40 | $1.38 | -1.4% | +2.1% | -8.4% | +2.3% | -16.4% | +11.6% |
| Mar 31 | D. Boral Capital | Maintains | Buy → Buy | — | $1.62 | $1.55 | -4.3% | -4.9% | -13.6% | +13.5% | +2.0% | -9.1% |
| Feb 24 | D. Boral Capital | Maintains | Buy → Buy | — | $1.70 | $1.79 | +5.3% | +0.0% | -2.4% | +0.0% | -1.2% | +0.6% |
| Feb 20 | D. Boral Capital | Maintains | Buy → Buy | — | $1.86 | $2.06 | +10.8% | +1.6% | -10.1% | +0.0% | -2.4% | +0.0% |
| Feb 4 | D. Boral Capital | Maintains | Buy → Buy | — | $1.75 | $1.73 | -1.1% | +10.3% | +8.8% | -7.6% | +1.0% | -3.1% |
| Jan 30 | D. Boral Capital | Maintains | Buy → Buy | — | $2.60 | $2.53 | -2.7% | -25.0% | -5.6% | -4.9% | +10.3% | +8.8% |
| Jan 16 | Maxim Group | Maintains | Buy → Buy | — | $4.36 | $4.27 | -2.1% | -5.5% | -28.4% | +5.8% | -2.9% | -3.6% |
| Jan 15 | D. Boral Capital | Maintains | Buy → Buy | — | $4.16 | $6.75 | +62.3% | +4.8% | -5.5% | -28.4% | +5.8% | -2.9% |
| Oct 3 | EF Hutton | Maintains | Buy → Buy | — | $2.91 | $2.89 | -0.7% | +3.3% | +9.1% | +0.0% | -4.0% | -0.6% |
| Sep 16 | EF Hutton | Maintains | Buy → Buy | — | $3.44 | $3.26 | -5.2% | +2.9% | -0.3% | -0.3% | +0.9% | -2.0% |
No insider trades available.
8-K · 1.01
! Medium
OS Therapies Incorporated -- 8-K 1.01: Equity Issuance
Aug 21
8-K · 1.01
!! High
OS Therapies Incorporated -- 8-K 1.01: Material Agreement
Jul 2
NT 10-Q
!! High
OS Therapies Incorporated -- Late Quarterly Report -- Distress Signal
May 15
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
OSTX secured $4.7M in funding through a placement agency agreement with Ceros Financial Services, providing capital for operations or growth while diluting existing shareholders through likely equity issuance.
Apr 2
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Osasuna (OSTX) completed a securities offering with warrants and convertible notes, providing capital but increasing dilution risk for existing shareholders through future conversion and warrant exercises.
Mar 31
8-K · 1.01
! Medium
OS Therapies Incorporated -- 8-K 1.01: Financing / Debt Agreement
OS Therapies engaged an SEC-registered broker-dealer as exclusive placement agent for a private placement, paying 7% of gross proceeds plus $25,000 in expense reimbursement.
Mar 6
8-K · 8.01
!! High
OS Therapies Incorporated -- 8-K 8.01: Material Event / Announcement
OS Therapies (OSTX) extended its warrant solicitation offering deadline by nearly three weeks to March 2, 2026, providing shareholders additional time to participate in the warrant exchange program.
Feb 13
Institutional (13F) — Top 0
All ↗
No 13F holders found.
Mutual Funds / ETFs (N-PORT) — Top 1
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Ultra-Small Company Market Fund | 25,000 | $35K | Mar 2026 |
Valuation
Market Cap
$74.7M
Enterprise Value
-$221.9M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
-0.02x
P/B
—
P/S
—
P/FCF
-0.00x
EV/EBITDA
—
Shares Out
29.3M
Financials (TTM)
Revenue
$0
Net Income
-$39.4M
EBITDA
-$38.7M
Free Cash Flow
-$14.24B
Op Cash Flow
-$14.24B
EPS Basic
$-0.98
EPS Diluted
$-1.09
EPS Forward
$-0.58
Gross Margin
—
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$6.8M
Total Liab.
$12.9M
Total Equity
-$6.1M
Cash
$269.8M
LT Debt
$0
Book Value/Sh
$-0.21
Debt/Equity
0.00x
Current Ratio
0.03
Quick Ratio
0.03
Returns & Growth
ROE
471.7%
ROA
-420.4%
ROIC
582.9%
Rev Growth YoY
+0.0%
EPS Growth YoY
-88.5%
Price Returns
2W
+1.2%
1M
+10.8%
3M
-23.4%
6M
+11.6%
12M
-31.4%
Technicals
52W High
$2.36
52W Low
$1.15
50d MA
$1.64
200d MA
$1.59
RSI (14)
50.80
ATR (14)
$0.08
Beta
-2.99
Avg Volume
332K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 6:03pm
· Source: financialmodelingprep.com